Publications by authors named "Ruby Mehta"

Claim this Profile
F
Food and Drug Administration Approval Summary: Odevixibat (Bylvay) for the Treatment of Pruritus With Progressive Familial Intrahepatic Cholestasis.
Sojeong Yi, Insook Kim, Rebecca Hager, Marian M Strazzeri, Lili Garrard, Ruby Mehta

Gastro Hep Adv· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Liver biopsy for assessment of suspected drug-induced liver injury in metabolic dysfunction-associated steatohepatitis clinical trials: Expert consensus from the Liver Forum.
Melissa Palmer, David E Kleiner, Zachary Goodman, Elizabeth Brunt, Mark I Avigan, Ruby Mehta

Aliment Pharmacol Ther· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing Pharmacokinetics in Liver Disease: Challenges and Future Considerations for Classification of Hepatic Dysfunction and Use of In Silico Methods.
Martina D Sahre, Daphne Guinn, Anuradha Ramamoorthy, Insook Kim, Xinyuan Zhang, Ruby Mehta, Mehul Mehta

J Clin Pharmacol· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nonalcoholic Steatohepatitis: Current Thinking From the Division of Hepatology and Nutrition at the Food and Drug Administration.
Frank A Anania, Lara Dimick-Santos, Ruby Mehta, Joseph Toerner, Julie Beitz

Hepatology· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Factors to Consider in Development of Drugs for Pediatric Nonalcoholic Fatty Liver Disease.
Miriam B Vos, Lara Dimick-Santos, Ruby Mehta, Stephanie O Omokaro, Johannes Taminiau

Gastroenterology· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design and Endpoints for Clinical Trials in Primary Sclerosing Cholangitis.
Cyriel Y Ponsioen, Keith D Lindor, Ruby Mehta, Lara Dimick-Santos

Hepatology· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Baseline Parameters in Clinical Trials for Nonalcoholic Steatohepatitis: Recommendations From the Liver Forum.
Yuval A Patel, Joanne C Imperial, Andrew J Muir, Quentin M Anstee, David DeBrota, Ruby Mehta

Gastroenterology· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
When fue goes wrong!
Arvind Poswal, Sangay Bhutia, Ruby Mehta

Indian J Dermatol· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
How long does it take for a trichobezoar to form?
Ruby Mehta, Mohammad F El-Baba, Janet M Poulik, Namir Al-Ansari

South Med J· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis